| Literature DB >> 31802136 |
Henk Jan Schuijt1,2, Jelle Bos3, Diederik Pieter Johan Smeeing3, Olivia Geraghty4, Detlef van der Velde3.
Abstract
PURPOSE: Orthogeriatric trauma patients are at risk for functional decline and mortality. It is important to identify high-risk patients in an early stage, to improve outcomes and make better informed treatment decisions. The aim of this study was to identify independent risk factors for 30-day mortality in patients aged 85 years or above admitted from the emergency department with a fracture.Entities:
Keywords: Fracture; Geriatric; Hip; Mortality; Orthogeriatric; Traumatology
Year: 2019 PMID: 31802136 PMCID: PMC8187176 DOI: 10.1007/s00068-019-01278-z
Source DB: PubMed Journal: Eur J Trauma Emerg Surg ISSN: 1863-9933 Impact factor: 3.693
Baseline characteristics of 30-day mortality vs. survivors. All percentages are calculated for valid data (i.e. excluding missing data)
| Characteristics | Total ( | Missing | 30-day mortality ( | Survivors ( | |
|---|---|---|---|---|---|
| Age, median (IQR) | 89 (87–92) | 0 | 90.5 (87–94) | 89 (87–92) | |
| Male sex, | 149 (22%) | 0 | 29 (34%) | 120 (20%) | |
| BMI (kg/m2), median (IQR) | 24 (21–26) | 180 | 21 (19–24) | 24 (22–26) | |
| Living situation, | 27 | ||||
| At home / at home with care | 350 (53%) | 36 | 29 (35%) | 321 (56%) | |
| Living in institutional care facility | 306 (47%) | 36 | 54 (64%) | 252 (44%) | |
| Living with partner, | 107 (16%) | 17 | 16 (19%) | 91 (15%) | 0.39 |
| Comorbidity | |||||
| Number of comorbidities, median (IQR) | 3 (2–5) | 62 | 4 (2–5) | 3 (2–5) | |
| Number of different medications, median (IQR) | 6 (4–8) | 69 | 7 (5–10) | 6 (4–8) | |
| Prior delirium, n (%) | 199 (31%) | 40 | 35 (44%) | 164 (29%) | |
| Impaired cognitive functioning, | 278 (42%) | 29 | 47 (57%) | 231 (40%) | |
| Use of oral anticoagulants, | 392 (62%) | 63 | 61 (78%) | 331 (60%) | |
| Biomarkers | |||||
| Hemoglobin (mmol/L), mean (SD) | 7.5 (1.0) | 88 | 7.2 (1.1) | 7.6 (1.0) | |
| Creatinine (µmol/L), median (IQR) | 79 (64–100) | 195 | 95 (74–109) | 78 (63–98) | |
| C-reactive protein (mg/L), median (IQR) | 5 (1–18) | 153 | 6 (1–31) | 5 (1–18) | 0.56 |
| Type of surgery, n (%) | 5 | 0.15 | |||
| Spinal column | 2 (0%) | 1 (1%) | 1 (0%) | ||
| Proximal humerus | 11 (2%) | 3 (4%) | 8 (1%) | ||
| Distal humerus | 2 (0%) | 0 (0%) | 2 (0%) | ||
| Hip fracture (proximal femur or collum) | 492 (72%) | 55 (65%) | 437 (73%) | ||
| Distal femur | 18 (3%) | 3 (4%) | 15 (3%) | ||
| Ankle | 19 (3%) | 0 (0%) | 19 (3%) | ||
| Other trauma surgical procedure | 1 (0%) | 0 (0%) | 1 (0%) | ||
| Conservative treatment | 142 (21%) | 23 (27%) | 119 (20%) | ||
| Type of anesthesia, | 13 | 0.57 | |||
| General | 452 (84%) | 52 (12%) | 400 (89%) | ||
| Regional | 85 (16%) | 8 (9%) | 77 (91%) | ||
| ASA classification, | 81 | ||||
| 1 | 14 (3%) | 0 (0%) | 14 (3%) | ||
| 2 | 217 (46%) | 17 (30%) | 200 (48%) | ||
| 3 | 230 (49%) | 34 (62%) | 196 (47%) | ||
| 4 | 8 (2%) | 4 (7%) | 4 (1%) | ||
| 5 | 0 (0%) | 0 (0%) | 0 (0%) |
aPercentages and missing data calculated for patients undergoing surgery
Significant differences presented in bold
Multivariable analysis for all admitted patients and subgroup analysis for all hip fracture patients undergoing surgery
| Initial cohort ( | Adjusted OR | 95% CI | |
|---|---|---|---|
| Age (per year above 85) | 1.11 | 1.04–1.18 | |
| Male sex | 2.96 | 1.68–5.23 | |
| Living in an institutional care facility | 2.31 | 1.34–3.99 | |
| Previous episode of delirium | 1.32 | 0.76–2.30 | 0.32 |
| Hemoglobin (each 1 mmol/L decrease) | 1.34 | 1.06–1.70 | |
| BMI (each point decrease) | 1.15 | 1.02–1.29 | |
| Use of oral anticoagulants | 2.22 | 0.88–5.56 | 0.09 |
| Surgical intervention for any fracture | 0.60 | 0.34–1.06 | 0.08 |
| Hip fracture patients undergoing surgery (n = 492) | |||
| Age (per year above 85) | 1.14 | 1.05–1.25 | |
| Male sex | 3.09 | 1.56–6.10 | |
| Living in an institutional care facility | 1.94 | 0.99–3.79 | 0.05 |
| Hemoglobin (each 1 mmol/L decrease) | 1.25 | 0.93–1.70 | 0.14 |
| BMI (each point decrease) | 1.22 | 1.02–1.46 | |
| ASA classification (per class increase) | 1.93 | 0.97–3.83 | 0.06 |
Significant differences presented in bold